EMEA-002342-PIP01-18

Key facts

Invented name
Verzenios
Active substance
abemaciclib
Therapeutic area
Oncology
Decision number
P/0124/2019
PIP number
EMEA-002342-PIP01-18
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of Ewing sarcoma
Route(s) of administration
Oral use
Contact for public enquiries
Eli Lilly and Company Limited

E-mail: wagle_asavari@lilly.com
Tel.  +1 3175448941

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating